mission, vision & ambition

Mission
In the execution of its statutory tasks, the Medicines Evaluation Board (MEB) adheres to the following mission statement.

The Medicines Evaluation Board evaluates and monitors the efficacy, the risks and the quality of human and veterinary medicinal products. The MEB also evaluates the safety of novel foods for human consumption.

Vision
The Medicines Evaluation Board has unique insight into the development, efficacy, risks, quality and post-marketing surveillance of medicinal products. As this knowledge may also benefit other areas of Dutch healthcare, the MEB proposes to apply its expertise more broadly and to continue developing it. Key priorities include transparency and the provision of information to healthcare professionals and patient organisations.

Ambition
The Medicines Evaluation Board invests in independence, scientific underpinning and patient orientation. In this way, we want to strengthen our role as a ‘gate keeper’. Although granting marketing authorisations is and will remain the MEB’s core activity, it is also the MEB’s ambition to make a significant contribution to innovation and the promotion of public health.